About this trial
The aim of the present study is to determine the prevalence of cardiometabolic and infectious disease in La Reunion (french oversea department and region of France).
Known or suspected risk factor for these diseases will also be assessed, such as microbiota, cognitive impairement, social inequalities, and genetics.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
18-67 years
given consent for genetic analysis,
written consent for participating in the study
Disqualifiers
judicial protection or guardianship
Trial population
Adult men and women ramdomly selected from the voter registration lists in La Réunion island
Trial design
Cohort
Prospective
Treatments tested in this trial
Blood, DNA, feces, urine, hair and skin microbiota collection
Diagnostic testSee above
Treatment groups
Trial outcomes
Primary outcomes
Prevalence of cardiometabolic diseases
Prevalence rates for diabetes, hypertension, obesity, dyslipidemia, smoking and subclinical atherosclerosis markers
Prevalence of infectious diseases
Seroprevalence rates for chikungunya, dengue, zika, covid19
Sponsors and contacts
Click on the lead sponsor to view all of their trials.